CSACI position statement: Newer generation H1-antihistamines are safer than first-generation H1-antihistamines and should be the first-line antihistamines for the treatment of allergic rhinitis and urticaria
Abstract Oral H1-antihistamines (AHs) are the most commonly used therapy to treat allergic rhinitis and chronic urticaria. Older, first-generation AHs (e.g. diphenhydramine, hydroxyzine) have significant and common side effects including sedation, impairment with decreased cognitive function, poor s...
Main Authors: | Michael N. Fein, David A. Fischer, Andrew W. O’Keefe, Gord L. Sussman |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-10-01
|
Series: | Allergy, Asthma & Clinical Immunology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13223-019-0375-9 |
Similar Items
-
Use of antihistamines in a physician's clinical practice
by: L V Luss
Published: (2014-08-01) -
Second-generation antihistamines
by: Pranjal Anil Mittal, et al.
Published: (2016-01-01) -
The Role of Cetirizine in the Changing Landscape of IV Antihistamines: A Narrative Review
by: Bernstein, J.A, et al.
Published: (2022) -
Actual antihistamine therapy
by: D. V. Shabanov, et al.
Published: (2020-11-01) -
Effects of Oral Antihistamines on Tear Volume, Tear Stability, and Intraocular Pressure
by: Brian K. Foutch, et al.
Published: (2020-06-01)